Fcr1p inhibits development of fluconazole resistance in Candida albicans by abolishing CDR1 induction

Biological and Pharmaceutical Bulletin

Volumn 30, Issue 1, 2007, Pages 68-73

  Shen, Hui ^a   An, Mao Mao ^b   Wang, De Jun ^a   Xu, Zheng ^a   Zhang, Jun Dong ^a   Gao, Ping Hui ^a   Cao, Ying Ying ^a   Cao, Yong Bing ^a   Jiang, Yuan Ying ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Candida albicans; CDR1; Drug resistance; FCR1

Indexed keywords

FLUCONAZOLE; FLUCONAZOLE RESISTANCE 1 PROTEIN; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC RESISTANCE; ARTICLE; CANDIDA ALBICANS; CANDIDA DRUG RESISTANCE 1 GENE; CANDIDIASIS; CONTROLLED STUDY; DOSE RESPONSE; DOWN REGULATION; DRUG EXPOSURE; FEMALE; FUNGAL GENE; FUNGAL STRAIN; GENE EXPRESSION; GENE INDUCTION; GENE OVEREXPRESSION; MOUSE; NONHUMAN;

ANIMALS; ANTIFUNGAL AGENTS; CANDIDA ALBICANS; CANDIDIASIS; DRUG RESISTANCE, FUNGAL; FEMALE; FLUCONAZOLE; FLUORESCENT DYES; FUNGAL PROTEINS; GENE EXPRESSION REGULATION, FUNGAL; KIDNEY; MEMBRANE TRANSPORT PROTEINS; METALLOPROTEINS; MICE; MICE, INBRED BALB C; MICROBIAL SENSITIVITY TESTS; MUTATION; RHODAMINES; RNA, MESSENGER; TIME FACTORS;

EID: 33846039892     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.30.68     Document Type: Article

References (40)

1. Ellis M., Richardson M., De Pauw B., Hosp. Med., 61, 605-609 (2000).
2. Garber G., Drugs, 61 (Suppl. 1), 1-12 (2001).
3. Maertens J., Vrebos M., Boogaerts M., Eur. J. Cancer Care (Engl.), 10, 56-62 (2001).
4. Pfaller M. A., Jones R. N., Doern G. V., Sader H. S., Messer S. A., Houston A., Coffman S., Hollis R. J., Antimicrob. Agents Chemother., 44, 747-751 (2000).
5. Vanden Bossche H., Warnock D. W., Dupont B., Kerridge D., Sen G. S., Improvisi L., Marichal P., Odds F. C., Provost F., Ronin O., J. Med. Vet. Mycol., 32 (Suppl. 1), 189-202 (1994).
6. Yang Y. L., Lo H. J., J. Microbiol. Immunol. Infect., 34, 79-86 (2001).
7. Boken D. J., Swindells S., Rinaldi M. G., Clin. Infect. Dis., 17, 1018-1021 (1993).
8. White T. C., Marr K. A., Bowden R. A., Clin. Microbiol. Rev., 11, 382-402 (1998).
9. Karababa M., Coste A. T., Rognon B., Bille J., Sanglard D., Antimicrob. Agents Chemother., 48, 3064-3079 (2004).
10. Marger M. D., Saier M. H., Jr., Trends Biochem. Sci., 18, 13-20 (1993).
11. Michaelis S., Berkower C., Cold Spring Harbor Symp. Quant. Biol., 60, 291-307 (1995).
12. Prasad R., De Wergifosse P., Goffeau A., Balzi E., Curr. Genet., 27, 320-329 (1995).
13. Sanglard D., Ischer F., Monod M., Bille J., Antimicrob. Agents Chemother., 40, 2300-2305 (1996).
14. Lopez-Ribot J. L., McAtee R. K., Perea S., Kirkpatrick W. R., Rinaldi M. G., Patterson T. F., Antimicrob. Agents Chemother., 43, 1621-1630 (1999).
15. Puri N., Krishnamurthy S., Habib S., Hasnain S. E., Goswami S. K., Prasad R., FEMS Microbiol. Lett., 180, 213-219 (1999).
16. Talibi D., Raymond M., J. Bacteriol., 181, 231-240 (1999).
17. Balzi E., Chen W., Ulaszewski S., Capieaux E., Goffeau A., J. Biol. Chem., 262, 16871-16879 (1987).
18. Balzi E., Wang M., Leterme S., Van Dyck L., Goffeau A., J. Biol. Chem., 269, 2206-2214 (1994).
19. Decottignies A., Lambert L., Catty P., Degand H., Epping E. A., Moye-Rowley W. S., Balzi E., Goffeau A., J. Biol. Chem., 270, 18150-18157 (1995).
20. Delahodde A., Delaveau T., Jacq C., Mol. Cell. Biol., 15, 4043-4051 (1995).
21. Delaveau T., Delahodde A., Carvajal E., Subik J., Jacq C., Mol. Gen. Genet., 244, 501-511 (1994).
22. Dexter D., Moye-Rowley W. S., Wu A. L., Golin J., Genetics, 136, 505-515 (1994).
23. Hallstrom T. C., Moye-Rowley W. S., J. Biol. Chem., 273, 2098-2104 (1998).
24. Katzmann D. J., Burnett P. E., Golin J., Mahe Y., Moye-Rowley W. S., Mol. Cell. Biol., 14, 4653-4661 (1994).
25. Katzmann D. J., Hallstrom T. C., Mahe Y., Moye-Rowley W. S., J. Biol. Chem., 271, 23049-23054 (1996).
26. Katzmann D. J., Hallstrom T. C., Voet M., Wysock W., Golin J., Volckaert G., Moye-Rowley W. S., Mol. Cell. Biol., 15, 6875-6883 (1995).
27. Mahé Y., Parle-McDermott A., Nourani A., Delahodde A., Lamprecht A., Kuchler K., Mol. Microbiol., 20, 109-117 (1996).
28. Meyers S., Schauer W., Balzi E., Wagner M., Goffeau A., Golin J., Curr. Genet., 21, 431-436 (1992).
29. National Committee for Clinical Laboratory Standards, Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard. Document M27-A2. National Committee for Clinical Laboratory Standards, Wayne, Pa., 2002.
30. Mukhopadhyay K., Kohli A., Prasad R., Antimicrob. Agents Chemother., 46, 3695-3705 (2002).
31. Sanglard D., Kuchler K., Ischer F., Pagani J. L., Monod M., Bille J., Antimicrob. Agents Chemother., 39, 2378-2386 (1995).
32. White T. C., Antimicrob. Agents Chemother., 41, 1482-1487 (1997).
33. Franz R., Kelly S. L., Lamb D. C., Kelly D. E., Ruhnke M., Morshhauser J., Antimicrob. Agents Chemother., 42, 3065-3072 (1998).
34. Loffler J., Kelly S. L., Hebart H., Schumacher U., Lass-Florl C., Einsele H., FEMS Microbiol. Lett., 151, 263-268 (1997).
35. Perea S., Lopez-Ribot J. L., Kirkpatrick W. R., McAtee R. K., Santillan R. A., Martinez M., Calabrese D., Sanglard D., Patterson T. F., Antimicrob. Agents Chemother., 45, 2676-2684 (2001).
36. Sanglard D., Ischer F., Koymans L., Bille J., Antimicrob. Agents Chemother., 42, 241-253 (1998).
37. Vanden Bossche H., Marichal P., Gorrens J., Bellens D., Moereels H., Janssen P. A., Biochem. Soc. Trans., 18, 56-59 (1990).
38. White T. C., Antimicrob. Agents Chemother., 41, 1488-1494 (1997).
39. Sanglard D., Ischer F., Monod M., Bille J., Microbiology, 143, 405-416 (1997).
40. Maesaki S., Marichal P., Vanden Bossche H., Sanglard D., Kohno S., J. Antimicrob. Chemother, 44, 27-31 (1999).